Grifols SA Sustainability Reports

Grifols, S.A. is a global healthcare company that specializes in the development, production, and distribution of plasma-derived medicines and transfusion medicine solutions.

Sector: Manufacturing

Country: Spain

Exchange: Bolsa de Madrid (BME)

LEI: 959800HSSNXWRKBK4N60

FIGI: BBG001SPWLV5

41 reports from 2012 to 2026

• Grifols SA 2026 Climate Transition Plan Executive Summary
• Grifols SA 2026 Human Rights Due Diligence Report
• Grifols SA 2025 Annual Corporate Governance Report of Listed Public Limited Companies
• Grifols SA 2025 Modern Slavery and Supply Chain Transparency Statement
• Grifols SA 2025 Climate Change Risk and Opportunity Analysis (ROCC)